LungLife AI, Inc.'s market cap is currently ―. The company's EPS TTM is p; its P/E ratio is ―; LungLife AI, Inc. is scheduled to report earnings on September 5, 2024, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Jun 22	Dec 21	Jun 21	Dec 20
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 8.01M	$ 10.63M	$ 14.63M	$ 120.73K	$ 127.63K
Total Assets	$ 15.02M	$ 17.68M	$ 21.97M	$ 580.17K	$ 774.10K
Total Debt	$ 601.00K	$ 694.00K	$ 808.90K	$ 12.16M	$ 10.63M
Net Debt	$ -7.41M	$ -9.94M	$ -13.82M	$ 12.04M	$ 10.50M
Total Liabilities	$ 1.88M	$ 1.62M	$ 1.84M	$ 16.19M	$ 12.08M
Stockholders Equity	$ 13.14M	$ 16.06M	$ 20.13M	$ -15.61M	$ -11.31M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in USD

LungLife AI, Inc. Earnings and Revenue History

Income Statement >

LungLife AI, Inc. Debt to Assets

Balance Sheet >

LungLife AI, Inc. Cash Flow

Cash Flow >

LungLife AI, Inc. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing